FDA Investigates COVID Vaccine Deaths
Analysis based on 6 articles · First reported Dec 10, 2025 · Last updated Dec 10, 2025
The United States — Food and Drug Administration's investigation into COVID-19 vaccine deaths, driven by the Donald Trump administration's new vaccine policy under Robert F. Kennedy Jr., introduces uncertainty for pharmaceutical companies involved in vaccine production. This shift could lead to increased regulatory scrutiny and potentially impact public trust in vaccines, affecting the healthcare and pharmaceutical industries.
The United States — Food and Drug Administration has launched a broad investigation into deaths potentially linked to COVID-19 vaccines. This probe follows Donald Trump's appointment of Robert F. Kennedy Jr., a known vaccine skeptic, as health secretary, which has led to a significant overhaul of vaccine policy in the United States. The review, initially focused on child deaths, expanded after a leaked internal document claimed a link between vaccines and infant deaths without evidence. Medical experts have expressed concern over the United States — Food and Drug Administration's direction under Robert F. Kennedy Jr.'s leadership, citing his history of spreading misinformation. Andrew Nixon, a spokesperson for the health and human services department, confirmed the investigation but declined to provide details on its methods or timeline. The efficacy and safety of COVID-19 vaccines have been widely studied and documented globally, with health authorities affirming their benefits despite rare severe side effects.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard